Ae Wealth Management LLC Novavax Inc Transaction History

Ae Wealth Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$36.28 - $75.29 $191,050 - $396,477	-5,266 Closed	0 $0
Q1 2022 Apr 18, 2022	BUY	$69.73 - $142.9 $155,079 - $317,809	2,224 Added 73.11%	5,266 $388,000
Q4 2021 Jan 20, 2022	BUY	$134.56 - $217.97 $119,354 - $193,339	887 Added 41.16%	3,042 $435,000
Q3 2021 Nov 01, 2021	BUY	$177.8 - $270.58 $69,697 - $106,067	392 Added 22.23%	2,155 $447,000
Q2 2021 Jul 21, 2021	BUY	$121.0 - $257.67 $75,141 - $160,013	621 Added 54.38%	1,763 $374,000
Q1 2021 Apr 27, 2021	SELL	$112.98 - $319.93 $625,344 - $1.77 Million	-5,535 Reduced 82.9%	1,142 $207,000
Q4 2020 Feb 01, 2021	BUY	$78.74 - $139.5 $238,897 - $423,243	3,034 Added 83.28%	6,677 $745,000
Q3 2020 Nov 06, 2020	BUY	$79.44 - $178.51 $65,855 - $147,984	829 Added 29.46%	3,643 $395,000
Q2 2020 Aug 05, 2020	BUY	$13.86 - $83.61 $39,002 - $235,278	2,814 New	2,814 $235,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.